ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,703, issued on Aug. 19, was assigned to CASE WESTERN RESERVE UNIVERSITY (Cleveland) and UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER (Cleveland).
"Aldoketo reductase inhibitors and uses thereof" was invented by William Greenlee (Shaker Heights, Ohio), Jonathan S. Stamler (Cleveland) and Focco van den Akker (Shaker Heights, Ohio).
According to the abstract* released by the U.S. Patent & Trademark Office: "An aldoketo reductase inhibitor includes a xanthene analogue."
The patent was filed on Sept. 23, 2020, under Application No. 17/762,793.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITO...